company background image
HM6A logo

Hypera BST:HM6A Stock Report

Last Price

€5.25

Market Cap

€2.7b

7D

0%

1Y

-14.6%

Updated

01 Oct, 2024

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Hypera S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hypera
Historical stock prices
Current Share PriceR$5.25
52 Week HighR$6.85
52 Week LowR$4.40
Beta0.44
1 Month Change0%
3 Month Changen/a
1 Year Change-14.63%
3 Year Change21.53%
5 Year Change-21.64%
Change since IPO6.04%

Recent News & Updates

Recent updates

Shareholder Returns

HM6ADE PharmaceuticalsDE Market
7D0%1.4%0.5%
1Y-14.6%-16.3%7.2%

Return vs Industry: HM6A underperformed the German Pharmaceuticals industry which returned -11.5% over the past year.

Return vs Market: HM6A underperformed the German Market which returned 13.3% over the past year.

Price Volatility

Is HM6A's price volatile compared to industry and market?
HM6A volatility
HM6A Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.4%

Stable Share Price: HM6A has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine HM6A's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199910,301Breno Pires de Oliveirawww.hypera.com.br

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand.

Hypera S.A. Fundamentals Summary

How do Hypera's earnings and revenue compare to its market cap?
HM6A fundamental statistics
Market cap€2.75b
Earnings (TTM)€280.32m
Revenue (TTM)€1.32b

9.8x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HM6A income statement (TTM)
RevenueR$8.00b
Cost of RevenueR$3.05b
Gross ProfitR$4.95b
Other ExpensesR$3.26b
EarningsR$1.69b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 06, 2024

Earnings per share (EPS)2.68
Gross Margin61.86%
Net Profit Margin21.17%
Debt/Equity Ratio84.8%

How did HM6A perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

30%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/01 21:11
End of Day Share Price 2024/07/04 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hypera S.A. is covered by 32 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andréa AznarBB Banco de Investimento S.A.
Georgia JorgeBB Banco de Investimento S.A.
Robert Ford AguilarBofA Global Research